SCHEMBL2182238

SCHEMBL2182238

CC(=O)OCc1nc(N(C)C)c2ccccc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.48
▸ KDM4E B2RXH2 6/20 0.48
▸ CYP2D6 P10635 6/20 0.48
▸ CYP3A4 P08684 4/20 0.48
▸ HPGD P15428 2/20 0.48
▸ HIF1A Q16665 2/20 0.48
▸ TP53 P04637 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ RECQL P46063 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ HTT P42858 1/20 0.46
▸ CYP1A2 P05177 6/20 0.45
▸ CYP2C19 P33261 4/20 0.45
▸ PDE10A Q9Y233 3/20 0.44
▸ TSHR P16473 7/20 0.44
▸ LMNA P02545 3/20 0.43
▸ GLA P06280 2/20 0.43
▸ CYP2C9 P11712 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2180130 0.80 ALDH1A1 (0.47) ALDH1A1KDM4EMEN1KMT2ARECQL
SCHEMBL2178309 0.77 SMN1; SMN2 (0.58) ALDH1A1KDM4ECYP2D6CYP3A4HPGD
SCHEMBL15457190 0.76 SMN1; SMN2 (0.56) ALDH1A1KDM4ECYP2D6CYP3A4HPGD
SCHEMBL638079 0.74 SMN1; SMN2 (0.54) ALDH1A1KDM4ECYP2D6CYP3A4HPGD
SCHEMBL2181702 0.74 CYP1A2 (0.44) ALDH1A1KDM4ECYP3A4HPGDHIF1A
SCHEMBL2186212 0.74 SMN1; SMN2 (0.50) ALDH1A1KDM4ECYP2D6CYP3A4HPGD
SCHEMBL2180512 0.73 CYP2D6 (0.55) ALDH1A1KDM4ECYP2D6CYP3A4HPGD
SCHEMBL12409984 0.73 SMN1; SMN2 (0.53) ALDH1A1KDM4ECYP2D6CYP3A4HPGD
SCHEMBL13458340 0.69 SMN1; SMN2 (0.59) ALDH1A1KDM4ECYP2D6CYP3A4HPGD
SCHEMBL3396098 0.69 ALDH1A1 (0.49) ALDH1A1KDM4EHPGDKMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2342191-B1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE MITSUBISHI TANABE PHARMA CORP (JP) 2013-03-20 — — EP disclosed
EP-2342191-B1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE MITSUBISHI TANABE PHARMA CORP (JP) 2013-03-20 — — EP disclosed
EP-2342191-A1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE Mitsubishi Tanabe Pharma Corporation (JP) 2011-07-13 — — EP disclosed
US-20110166135-A1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-07-07 — — US disclosed
US-20110166135-A1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-07-07 — — US disclosed
WO-2010030027-A1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-03-18 — — WO disclosed
WO-2010030027-A1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-03-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166135-A1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE PDE10A, PDE3A, PDE3B ALDH1A1 1520/4885KDM4E 397/4885CYP2D6 379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback